Anavex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. 

CEO
Terrie Kellmeyer
CEOTerrie Kellmeyer
Employees
34
Employees34
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2004
Founded2004
Employees
34
Employees34

AVXL Key Statistics

Market cap
122.36M
Market cap122.36M
Price-Earnings ratio
-8.97
Price-Earnings ratio-8.97
Dividend yield
—
Dividend yield—
Average volume
1.38M
Average volume1.38M
High today
$1.35
High today$1.35
Low today
$1.29
Low today$1.29
Open price
$1.34
Open price$1.34
Volume
627.21K
Volume627.21K
52 Week high
$9.40
52 Week high$9.40
52 Week low
$1.14
52 Week low$1.14

Stock Snapshot

The current Anavex(AVXL) stock price is $1.29, with a market capitalization of 122.36M. The stock trades at a price-to-earnings (P/E) ratio of -8.97.

On 2026-10-23, Anavex(AVXL) stock traded between a low of $1.29 and a high of $1.35. Shares are currently priced at $1.29, which is 0.0% above the low and -4.4% below the high.

Anavex(AVXL) shares are trading with a volume of 627.21K, against a daily average of 1.38M.

During the past year, Anavex(AVXL) stock moved between $1.14 at its lowest and $9.40 at its peak.

During the past year, Anavex(AVXL) stock moved between $1.14 at its lowest and $9.40 at its peak.

AVXL News

TipRanks 3d
Anavex Advances Blarcamesine Clinical Pharmacology and Rare-Disease Programs

Anavex Life Sciences ( (AVXL) ) has issued an announcement. On October 20, 2026, Anavex reported completion of the clinical conduct of two key pharmacology stu...

Investing.com 3d
Anavex completes drug studies for Alzheimer’s treatment candidate - Investing.com

...

Anavex completes drug studies for Alzheimer’s treatment candidate - Investing.com

People also own

Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.